疫苗接种后早期时代的宫颈癌筛查

Cervical cancer screening in the early post vaccine era.

作者信息

Waxman Alan G

机构信息

Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, University of New Mexico, MSC10 5580, Albuquerque, NM 87131-0001, USA.

出版信息

Obstet Gynecol Clin North Am. 2008 Dec;35(4):537-48; vii. doi: 10.1016/j.ogc.2008.09.005.

DOI:10.1016/j.ogc.2008.09.005

PMID:19061815

Abstract

The Pap test is the foundation of cervical cancer screening in North America and most industrialized countries. It has been widely used in the United States since the 1950s. But are our current screening guidelines still justified? In this article, the author reviews the current recommendations for cervical cancer screening by the American Cancer Society (ACS) and the American College of Obstetricians and Gynecologists (ACOG) and the evidence supporting them, reviews the relative efficacy of liquid-based cytology versus the conventional Pap smear, and discusses the role of HPV DNA testing in primary screening.

摘要

巴氏试验是北美和大多数工业化国家宫颈癌筛查的基础。自20世纪50年代以来，它在美国得到了广泛应用。但我们目前的筛查指南是否仍然合理呢？在本文中，作者回顾了美国癌症协会（ACS）和美国妇产科医师学会（ACOG）目前关于宫颈癌筛查的建议以及支持这些建议的证据，回顾了液基细胞学与传统巴氏涂片的相对有效性，并讨论了HPV DNA检测在初次筛查中的作用。